Omaveloxolone: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Omaveloxolone. Educational only — not medical advice.
Labeled uses
SKYCLARYS is indicated for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older.
Source: FDA labeling via NIH DailyMed (set f1a1100e…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.